Hepatocyte Growth Factor and Lung Fibrosis
- 15 July 2012
- journal article
- Published by American Thoracic Society in Proceedings of the American Thoracic Society
- Vol. 9 (3), 158-163
- https://doi.org/10.1513/pats.201202-018aw
Abstract
Idiopathic pulmonary fibrosis is currently believed to be driven by alveolar epithelial cells, with abnormally activated alveolar epithelial cells accumulating in an attempt to repair injured alveolar epithelium (1). Thus, targeting the alveolar epithelium to prevent or inhibit the development of pulmonary fibrosis might be an interesting therapeutic option in this disease. Hepatocyte growth factor (HGF) is a growth factor for epithelial and endothelial cells, which is secreted by different cell types, especially fibroblasts and neutrophils. HGF has mitogenic, motogenic, and morphogenic properties and exerts an antiapoptotic action on epithelial and endothelial cells. HGF has also proangiogenic effect. In vitro, HGF inhibits epithelial-to-mesenchymal cell transition and promotes myofibroblast apoptosis. In vivo, HGF has antifibrotic properties demonstrated in experimental models of lung, kidney, heart, skin, and liver fibrosis. Hence, the modulation of HGF may be an attractive target for the treatment of lung fibrosis.Keywords
This publication has 80 references indexed in Scilit:
- Identification of Mannose Receptor as Receptor for Hepatocyte Growth Factor β-ChainOnline Journal of Public Health Informatics, 2012
- Paracrine Factors of Multipotent Stromal Cells Ameliorate Lung Injury in an Elastase-induced Emphysema ModelMolecular Therapy, 2011
- Hepatocyte Growth Factor Inhibits Apoptosis by the Profibrotic Factor Angiotensin II via Extracellular Signal-regulated Kinase 1/2 in Endothelial Cells and Tissue ExplantsMolecular Biology of the Cell, 2010
- The antifibrotic effects of plasminogen activation occur via prostaglandin E2 synthesis in humans and miceJCI Insight, 2010
- Deletion of the Met receptor in the collecting duct decreases renal repair following ureteral obstructionKidney International, 2009
- Hepatocyte Growth Factor Inhibits Epithelial to Myofibroblast Transition in Lung Cells via Smad7American Journal of Respiratory Cell and Molecular Biology, 2009
- Hepatocyte growth factor regulates cyclooxygenase-2 expression via β-catenin, Akt, and p42/p44 MAPK in human bronchial epithelial cellsAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2008
- The shadow of death on the MET tyrosine kinase receptorCell Death & Differentiation, 2007
- c-Met is essential for wound healing in the skinThe Journal of cell biology, 2007
- Hepatocyte growth factor induces angiogenesis in injured lungs through mobilizing endothelial progenitor cellsBiochemical and Biophysical Research Communications, 2004